OR WAIT null SECS
There are considerations companies may want to consider before seeking out a service provider.
Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.
Demand for efficient tech transfer, as well as compliant on-time delivery, is rising.
September 24, 2024
Under the long-term supply agreement, Lonza will manufacture CASGEVY (exagamglogene autotemcel) for Vertex at its facility in Geleen, the Netherlands, and plans to expand manufacturing to Portsmouth, NH, in the United States.
September 04, 2024
Rentschler Biopharma now offers a new lentiviral vector manufacturing toolbox at its site in Stevenage, UK.
As the field of bioanalytical testing evolves, it is important for drug developers to stay at the forefront of the advancements to ensure they remain competitive.
August 23, 2024
Christian Cobaugh, CEO and founder of Vernal Biosciences, considers the outsourcing landscape for mRNA production.
August 04, 2024
Contract organizations offer sponsors specialized equipment, capacity, and expertise for testing, manufacturing, and packaging bio/pharmaceutical products.
July 22, 2024
The addition of BIOVECTRA’s biologics capabilities to accelerate drug development and manufacturing will allow Agilent to expand its end-to-end offerings for biopharma services.
July 19, 2024
Pluri’s newly launched CDMO business will manufacture two novel cell therapy product candidates for Kadimastem.
July 12, 2024
With the acquisition, Olink will join Thermo Fisher’s Life Sciences Solutions business.
July 03, 2024
This collaboration aims to support and accelerate clinical development of advanced and novel technologies.
June 26, 2024
The pairing of Abzena and Argonaut Manufacturing Services is the result of several years’ worth of collaborative work between the two companies.